Cannabis Science Inc (CBIS) financial statements (2020 and earlier)

Company profile

Business Address 19800 MACARTHUR BLVD., SUITE #300
IRVINE, CA 92612
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments00000
Cash and cash equivalents00000
Receivables00 00
Inventory, net of allowances, customer advances and progress billings00 
Inventory00   
Other undisclosed current assets10001
Total current assets:10001
Noncurrent Assets
Property, plant and equipment   00
Long-term investments and receivables00001
Long-term investments00001
Intangible assets, net (including goodwill)10 00
Goodwill 0 00
Intangible assets, net (excluding goodwill)10 00
Prepaid expense  44
Other undisclosed noncurrent assets01(3)(4)(1)
Total noncurrent assets:11100
TOTAL ASSETS:22111
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities23221
Accounts payable11000
Accrued liabilities12211
Employee-related liabilities00   
Debt0    
Due to related parties10000
Other undisclosed current liabilities212 2
Total current liabilities:44423
Noncurrent Liabilities
Other undisclosed liabilities   2 
Total liabilities:44443
Stockholders' equity
Stockholders' equity attributable to parent, including:(1)(2)(3)(4)(2)
Preferred stock00000
Common stock22111
Common stock, share subscribed but unissued, subscriptions receivable(1)(0)   
Additional paid in capital1371281109287
Deferred compensation equity(2)(3)   
Retained earnings (accumulated deficit)(138)(128)(109)(93)87
Other undisclosed stockholders' equity attributable to parent(0)(0)(4)(4)(176)
Stockholders' equity attributable to noncontrolling interest(1)(1)   
Total stockholders' equity:(2)(3)(3)(4)(2)
TOTAL LIABILITIES AND EQUITY:22111

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues00000
Revenue, net   00
Financial services revenue   0 
Cost of revenue
(Cost of Goods and Services Sold)
(0)(7)(4)(1)(0)
Gross profit:0(7)(4)(1)(0)
Operating expenses(9)(19)(16)(3)(17)
Other undisclosed operating income 7410
Operating loss:(9)(19)(16)(3)(17)
Nonoperating expense(1)(0)(1)  
Investment income, nonoperating(1) (0)  
Interest and debt expense(1)(6)(5)(2)(0)
Loss from continuing operations before equity method investments, income taxes:(11)(25)(22)(6)(17)
Other undisclosed income (loss) from continuing operations before income taxes   (0)1
Net loss:(11)(25)(22)(6)(16)
Net income attributable to noncontrolling interest01   
Other undisclosed net income (loss) attributable to parent155 (0)
Net loss attributable to parent:(10)(19)(17)(6)(16)
Other undisclosed net income available to common stockholders, basic01   
Net loss available to common stockholders, diluted:(10)(19)(17)(6)(16)

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(11)(25)(22)(6)(16)
Other comprehensive income (loss) (0)0  
Comprehensive loss:(11)(25)(22)(6)(16)
Comprehensive income, net of tax, attributable to noncontrolling interest01   
Other undisclosed comprehensive income, net of tax, attributable to parent165  
Comprehensive loss, net of tax, attributable to parent:(10)(19)(17)(6)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: